Arcus Biosciences (RCUS) Insider Trading & Ownership $16.47 +0.74 (+4.70%) (As of 11/7/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arcus Biosciences (NYSE:RCUS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$320.00 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.58 M Get RCUS Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcus Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCUS Insider Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Arcus Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2024Jennifer JarrettCOOSell11,551$17.55$202,720.05 3/18/2024Jennifer JarrettCOOSell13,449$17.92$241,006.08 2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85 2/26/2024Juan C JaenPresidentSell3,900$20.06$78,234.00 1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.00 1/2/2024Juan C JaenPresidentSell6,975$20.09$140,127.75 1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.00 12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96 (Data available from 1/1/2013 forward) RCUS Insider Trading Activity - Frequently Asked Questions Who is on Arcus Biosciences's Insider Roster? The list of insiders at Arcus Biosciences includes Alexander Azoy, Carolyn C Tang, Gilead Sciences, Inc., Jennifer Jarrett, Juan C Jaen, Robert C Goeltz II, and Terry J Rosen. Learn more on insiders at RCUS. What percentage of Arcus Biosciences stock is owned by insiders? 12.30% of Arcus Biosciences stock is owned by insiders. Learn more on RCUS's insider holdings. Which Arcus Biosciences insiders have been buying company stock? The following insider purchased RCUS shares in the last 24 months: Gilead Sciences, Inc. ($339,452,595.00). How much insider buying is happening at Arcus Biosciences? Insiders have purchased a total of 16,248,095 RCUS shares in the last 24 months for a total of $339,452,595.00 bought. Which Arcus Biosciences insiders have been selling company stock? The following insiders have sold RCUS shares in the last 24 months: Alexander Azoy ($20,777.38), Carolyn C Tang ($77,582.25), Jennifer Jarrett ($3,798,687.73), Juan C Jaen ($354,768.75), Robert C Goeltz II ($115,509.75), and Terry J Rosen ($401,072.25). How much insider selling is happening at Arcus Biosciences? Insiders have sold a total of 224,308 Arcus Biosciences shares in the last 24 months for a total of $4,768,398.11 sold. Arcus Biosciences Key ExecutivesDr. Terry J. Rosen Ph.D. (Age 64)Co-Founder, Chairman & CEO Compensation: $756.11kDr. Juan Carlos Jaen Ph.D. (Age 66)Co- Founder & President Compensation: $931.14kMr. Robert C. Goeltz II (Age 51)Principal Financial Officer & CFO Compensation: $745.29kMs. Jennifer A. Jarrett M.B.A. (Age 53)Chief Operating Officer Compensation: $925.29kDr. Dimitry S.A. Nuyten M.D. (Age 48)Ph.D., Chief Medical Officer Compensation: $700.34kDr. K. Christopher Garcia Ph.D.Co-Founder & Member of Scientific Advisory BoardMr. Alexander Azoy (Age 48)VP of Finance & Principal Accounting Officer Dr. Jonathan Yingling Ph.D. (Age 55)Chief Scientific Officer More Insider Trading Tools from MarketBeat Related Companies Nuvalent Insider Buying Blueprint Medicines Insider Buying Krystal Biotech Insider Buying Avidity Biosciences Insider Buying Arcellx Insider Buying BridgeBio Pharma Insider Buying Organon & Co. Insider Buying Biohaven Insider Buying Crinetics Pharmaceuticals Insider Buying Ultragenyx Pharmaceutical Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors This page (NYSE:RCUS) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredUrgent: This election is riggedI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
